Cite
MLA Citation
Barbara Melosky et al.. “Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.” Lung cancer, vol. 133, 2019, pp. 48–55. http://access.bl.uk/ark:/81055/vdc_100085410484.0x00004f